Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

What is the TRULICITY® (dulaglutide) formulation?

The formulation of Trulicity (dulaglutide) consists of dulaglutide 1.5 mg or dulaglutide 0.75 mg in a solution with several other components.

Detailed Information

Dulaglutide is a clear, colorless, and sterile solution available as a

  • 0.75 mg/0.5 mL solution in a single-dose pen

  • 1.5 mg/0.5 mL solution in a single-dose pen

  • 3 mg/0.5 mL solution in a single-dose pen, and

  • 4.5 mg/0.5 mL solution in a single-dose pen.1

Each single-dose pen contains a 0.5-mL solution of 0.75 mg, 1.5 mg, 3 mg, or 4.5 mg of dulaglutide and excipients in water for injection that includes

  • 0.07 mg citric acid anhydrous

  • 23.2 mg mannitol, and

  • 1.37 mg trisodium citrate dihydrate.1 

Each-single dose pen also contains polysorbate 80 (0.10 mg for 0.75 mg and 1.5 mg; 0.125 mg for 3 mg and 4.5 mg).1

Enclosed Prescribing Information

TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly


1. Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.

Date of Last Review: August 24, 2020

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical